Literature DB >> 17464729

Prodromal symptoms to relapse in bipolar disorder.

Pilar Sierra1, Lorenzo Livianos, Sergio Arques, Javier Castelló, Luis Rojo.   

Abstract

In a cyclical and recurring illness such as bipolar disorder, prodrome detection is of vital importance. This paper describes manic and depressive prodromal symptoms to relapse, methods used in their detection, problems inherent in their assessment, and patients' coping strategies. A review of the literature on the issue was performed using MEDLINE and EMBASE databases (1965-May 2006). 'Bipolar disorder', 'prodromes', 'early symptoms', 'coping', 'manic' and 'depression' were entered as key words. A hand search was conducted simultaneously and the references of the articles found were used to locate additional articles. The most common depressive prodromes are mood changes, psychomotor symptoms and increased anxiety; the most frequent manic prodromes are sleep disturbances, psychotic symptoms and mood changes. The manic prodromes also last longer. Certain psychological interventions, both at the individual and psychoeducational group level, have proven effective, especially in preventing manic episodes. Bipolar patients are highly capable of detecting prodromal symptoms to relapse, although they do find the depressive ones harder to identify. Learning detection, coping strategies and idiosyncratic prodromes are elements that should be incorporated into daily clinical practice with bipolar patients.

Entities:  

Mesh:

Year:  2007        PMID: 17464729     DOI: 10.1080/00048670701266854

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  10 in total

1.  Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder.

Authors:  Gianluca Serafini; Gustavo H Vazquez; Xenia Gonda; Maurizio Pompili; Zoltan Rihmer; Mario Amore
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-07       Impact factor: 5.270

Review 2.  The role of circadian clock genes in mental disorders.

Authors:  Elaine Waddington Lamont; Daniel Legault-Coutu; Nicolas Cermakian; Diane B Boivin
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

3.  Detection of prodromal symptoms of relapse in mania and unipolar depression by relatives and patients.

Authors:  M K Sahoo; S Chakrabarti; P Kulhara
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

Review 4.  The role of sleep in bipolar disorder.

Authors:  Alexandra K Gold; Louisa G Sylvia
Journal:  Nat Sci Sleep       Date:  2016-06-29

Review 5.  Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus.

Authors:  Chelsea A Vadnie; Colleen A McClung
Journal:  Neural Plast       Date:  2017-11-05       Impact factor: 3.599

Review 6.  The Impact of Subsyndromal Bipolar Symptoms on Patient's Functionality and Quality of Life.

Authors:  Heinz Grunze; Christoph Born
Journal:  Front Psychiatry       Date:  2020-06-12       Impact factor: 4.157

7.  Stickiness of the blues: Chronicity of depression.

Authors:  G Swaminath
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

8.  Initial and relapse prodromes in adult patients with episodes of bipolar disorder: A systematic review.

Authors:  Nelson Andrade-González; Laura Álvarez-Cadenas; Jerónimo Saiz-Ruiz; Guillermo Lahera
Journal:  Eur Psychiatry       Date:  2020-02-12       Impact factor: 5.361

Review 9.  Microaggressions towards people affected by mental health problems: a scoping review.

Authors:  S Barber; P C Gronholm; S Ahuja; N Rüsch; G Thornicroft
Journal:  Epidemiol Psychiatr Sci       Date:  2019-12-16       Impact factor: 6.892

10.  Efficacy of early warning signals and spectral periodicity for predicting transitions in bipolar patients: An actigraphy study.

Authors:  Yoram K Kunkels; Harriëtte Riese; Stefan E Knapen; Rixt F Riemersma-van der Lek; Sandip V George; Arie M van Roon; Robert A Schoevers; Marieke Wichers
Journal:  Transl Psychiatry       Date:  2021-06-07       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.